SCHEMBL8790248

SCHEMBL8790248

COc1cc2c(cc1OC)CN(CCCc1cccc(N)c1)CC2

nearest known ligand 0.61

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 15/20 0.61
DHCR7 Q9UBM7 2/20 0.57
ABCG2 Q9UNQ0 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8789667 0.93 ABCB1 (0.67) ABCB1DHCR7ABCG2
SCHEMBL8790535 0.87 ABCB1 (0.68) ABCB1DHCR7ABCG2
SCHEMBL8790676 0.85 DHCR7 (0.61) ABCB1DHCR7ABCG2
SCHEMBL8788946 0.83 ABCB1 (0.67) ABCB1DHCR7ABCG2
SCHEMBL4663782 0.83 SIGMAR1 (0.63) ABCB1
SCHEMBL8790359 0.80 ABCB1 (0.57) ABCB1DHCR7ABCG2
SCHEMBL2771882 0.79 ABCB1 (0.78) ABCB1DHCR7ABCG2
SCHEMBL13896162 0.79 ABCB1 (0.73) ABCB1DHCR7ABCG2
Hydrochloric Acid SCHEMBL10661663 0.78 ABCB1 (0.76) ABCB1DHCR7ABCG2
SCHEMBL4049215 0.78 ABCB1 (0.75) ABCB1ABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0569380-B1 ACRIDINE DERIVATIVES GLAXO LAB SA (FR) 1997-05-28 EP disclosed
US-5604237-A IMPROVE OR INCREASE EFFICACY OF ANTITUMOR AGENT, INCREASE OR RESTORE SENSITIVITY OF TUMOR TO ANTITUMOR AGENT, REVERSE OR REDUCE RESISTANCE OF TUMOR TO ANTITUMOR AGENT LABORATOIRES GLAXO SA (FR) 1997-02-18 US disclosed
EP-0494623-A1 Acridine derivatives LABORATOIRES GLAXO SA (FR) 1992-07-15 EP disclosed